172 related articles for article (PubMed ID: 32457142)
1. Prosocial polio vaccination in Israel.
Wells CR; Huppert A; Fitzpatrick MC; Pandey A; Velan B; Singer BH; Bauch CT; Galvani AP
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13138-13144. PubMed ID: 32457142
[TBL] [Abstract][Full Text] [Related]
2. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
[TBL] [Abstract][Full Text] [Related]
3. Silent reintroduction of wild-type poliovirus to Israel, 2013 - risk communication challenges in an argumentative atmosphere.
Kaliner E; Moran-Gilad J; Grotto I; Somekh E; Kopel E; Gdalevich M; Shimron E; Amikam Y; Leventhal A; Lev B; Gamzu R
Euro Surveill; 2014 Feb; 19(7):20703. PubMed ID: 24576475
[TBL] [Abstract][Full Text] [Related]
4. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
5. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
6. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
7. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
8. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
[TBL] [Abstract][Full Text] [Related]
9. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.
Tulchinsky T; Abed Y; Shaheen S; Toubassi N; Sever Y; Schoenbaum M; Handsher R
Am J Public Health; 1989 Dec; 79(12):1648-52. PubMed ID: 2817193
[TBL] [Abstract][Full Text] [Related]
10. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.
Sheikh MA; Makokha F; Hussein AM; Mohamed G; Mach O; Humayun K; Okiror S; Abrar L; Nasibov O; Burton J; Unshur A; Wannemuehler K; Estivariz CF;
MMWR Morb Mortal Wkly Rep; 2014 Mar; 63(11):237-41. PubMed ID: 24647400
[TBL] [Abstract][Full Text] [Related]
11. Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013-14: a 'natural experiment'.
Flahault A; Orenstein W; Garon J; Kew O; Bickford J; Tulchinsky T
Int J Public Health; 2015 Nov; 60(7):765-6. PubMed ID: 26140857
[No Abstract] [Full Text] [Related]
12. Would it be legally justified to impose vaccination in Israel? Examining the issue in light of the 2013 detection of polio in Israeli sewage.
Kamin-Friedman S
Isr J Health Policy Res; 2017 Oct; 6(1):58. PubMed ID: 29084599
[TBL] [Abstract][Full Text] [Related]
13. Risk management in a polio-free world.
Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
[TBL] [Abstract][Full Text] [Related]
14. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
15. Infectious disease. Israel's silent polio epidemic breaks all the rules.
Roberts L
Science; 2013 Nov; 342(6159):679-80. PubMed ID: 24202150
[No Abstract] [Full Text] [Related]
16. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
[TBL] [Abstract][Full Text] [Related]
17. Insidious reintroduction of wild poliovirus into Israel, 2013.
Anis E; Kopel E; Singer SR; Kaliner E; Moerman L; Moran-Gilad J; Sofer D; Manor Y; Shulman LM; Mendelson E; Gdalevich M; Lev B; Gamzu R; Grotto I
Euro Surveill; 2013 Sep; 18(38):. PubMed ID: 24084337
[TBL] [Abstract][Full Text] [Related]
18. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
Kalkowska DA; Duintjer Tebbens RJ; Grotto I; Shulman LM; Anis E; Wassilak SG; Pallansch MA; Thompson KM
J Infect Dis; 2015 Jun; 211(11):1800-12. PubMed ID: 25505296
[TBL] [Abstract][Full Text] [Related]
19. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
20. The polio endgame.
Minor P
Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
